| Literature DB >> 28648619 |
Bente Berg Johansson1, Karianne Fjeld2, Marie Holm Solheim3, Jun Shirakawa4, Enming Zhang5, Magdalena Keindl6, Jiang Hu7, Andreas Lindqvist5, Anne Døskeland8, Gunnar Mellgren9, Torgeir Flatmark10, Pål Rasmus Njølstad11, Rohit N Kulkarni7, Nils Wierup5, Ingvild Aukrust2, Lise Bjørkhaug12.
Abstract
The localization of glucokinase in pancreatic beta-cell nuclei is a controversial issue. Although previous reports suggest such a localization, the mechanism for its import has so far not been identified. Using immunofluorescence, subcellular fractionation and mass spectrometry, we present evidence in support of glucokinase localization in beta-cell nuclei of human and mouse pancreatic sections, as well as in human and mouse isolated islets, and murine MIN6 cells. We have identified a conserved, seven-residue nuclear localization signal (30LKKVMRR36) in the human enzyme. Substituting the residues KK31,32 and RR35,36 with AA led to a loss of its nuclear localization in transfected cells. Furthermore, our data indicates that SUMOylation of glucokinase modulates its nuclear import, while high glucose concentrations do not significantly alter the enzyme nuclear/cytosolic ratio. Thus, for the first time, we provide data in support of a nuclear import of glucokinase mediated by a redundant mechanism, involving a nuclear localization signal, and which is modulated by its SUMOylation. These findings add new knowledge to the functional role of glucokinase in the pancreatic beta-cell.Entities:
Keywords: Beta-cells; Glucokinase; Human islets; MIN6 cells; Nuclear localization signal; Pancreatic islets; SUMOylation
Mesh:
Substances:
Year: 2017 PMID: 28648619 DOI: 10.1016/j.mce.2017.06.020
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN: 0303-7207 Impact factor: 4.102